|
1) Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009; 361: 947-57
|
|
|
|
2) Mitsudomi T, Morita S, Yatabe Y, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial. Lancet Oncol. 2010; 11: 121-8
|
|
|
|
|
|
3) Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR. N Engl J Med. 2010; 362: 2380-8
|
|
|
|
|
|
4) 光冨徹哉, 谷田部恭, 萩原弘一, 他. 肺癌患者におけるEGFR遺伝子変異検査の解説. 解説作成委員, 編. 日本肺癌学会; 2009
|
|
|
|
|
|
5) Goto K, Ishii G, Todo T, et al. Validation study of EGFR mutation tests using DNA from control admixture samples and formalin-fixed paraffin embedded (FFPE) samples from non-small cell lung cancer (NSCLC) patients in the diagnostic setting. Ann Oncol. 2010; 21(Supp18): abstract 382
|
|
|
|
|
|
6) Satouchi M, Ishii G, Todo T, et al. Validation study of EGFR mutation tests using bronchofiberscopic brushing cytology samples and pleural effusion form non-small cell lung cancer (NSCLC) patients in the diagnostic setting. Ann Oncol. 2010; 21(Supp18): abstract 385
|
|
|
|
|
|
7) 藤本英也, 古本奈緒美, 武田昌久, 他. 当社におけるPNA-LNA PCR clamp法を用いたEGFR遺伝子変異解析の状況について. 病理技術. 2010; 73: 67-9
|
|
|
|
|
|
8) Pirker R, Herth FJ, Kerr KM, et al. Consensus for EGFR mutation testing in non-small cell lung cancer: results from a European workshop. J Thorac Oncol. 2010; 5: 1706-13
|
|
|
|
|
|
9) http://www.cap.org/apps/cap.portal？_nfpb=true&_pageLabel=reference
|
|
|
|
|
|
10) Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011; 6: 244-85
|
|
|
|
|
|
11) West HL, Franklin WA, McCoy J, et al. Gefitinib therapy in advanced bronchioloalveolar carcinoma: Southwest Oncology Group Study S0126. J Clin Oncol. 2006; 24: 1807-13
|
|
|
|
|